GFPT1 and urinary bladder cancer: Exosomal GFAT1 derived from bladder cancer was reported to promote tumor angiogenesis by inducing HBP-related metabolic reprogramming and SerRS O-GlcNAcylation in endothelial cells, this may shed light on novel targets for bladder cancer antiangiogenetic therapy [99].